Boulder, CO, United States of America

Michael G Kahn

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Clinical Trials: The Contributions of Michael G Kahn

Introduction: Michael G Kahn, an inventive force based in Boulder, Colorado, has made significant strides in the field of clinical trials through his innovative technologies. With a total of five patents to his name, Kahn's work focuses on enhancing clinical trial efficiency and patient management.

Latest Patents: Among Kahn's notable inventions is a cutting-edge Clinical Trials Management System that integrates protocol meta-models for clinical trial designers. This system allows protocol designers to select from a list of patient eligibility attributes tailored to specific disease categories. Once a patient is enrolled, the protocol database assists clinicians by outlining necessary tasks for each visit, covering both patient management and data management needs. Another remarkable invention of Kahn's aids in creating structured clinical trial protocol databases. It allows users to instantiate protocol elements quickly while drawing from a historical database to enhance task selection. This system automatically generates content and provides advisories for incomplete sections, ensuring that all aspects of the protocol are addressed before the trial begins.

Career Highlights: Michael Kahn has had a distinguished career, working with prominent companies in the clinical trial management landscape. He is known for his roles at Medidata Solutions, Inc. and Fasttrack Systems, Inc., where he contributed to advancing clinical trial processes and technologies.

Collaborations: Throughout his career, Kahn has collaborated with talented professionals such as Carol A Broverman and Michael Mischke-Reeds. Their joint efforts have further strengthened the development of innovative solutions for clinical trials.

Conclusion: Michael G Kahn's innovative contributions to clinical trial management are shaping the future of research methodologies. His patented systems not only simplify the design of clinical trial protocols but also enhance patient care and data management, demonstrating the profound impact of innovation in the realm of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…